Capital International Investors Portfolio holdings
Capital International, established in 1968 as a division of the Los Angeles-based Capital Group, is a global investment management firm focused on delivering equity investment solutions for institutional and individual clients worldwide. Operating as part of one of the oldest and largest asset managers, founded in 1931, it leverages Capital Group’s signature research-driven, long-term investment philosophy, managing billions in assets through a multi-manager system that diversifies risk and enhances performance. Headquartered in Los Angeles with a presence across North America, Europe, and Asia, Capital International specializes in international and global equity strategies, often through mutual funds like those in the American Funds family. Known for its rigorous fundamental analysis and commitment to client outcomes, it plays a key role in Capital Group’s mission to provide consistent, superior returns in global markets.
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
$454M |
| 2 |
Philip Morris
PM
|
$366M |
| 3 |
Altria Group
MO
|
$359M |
| 4 |
Coca-Cola
KO
|
$297M |
| 5 |
Microsoft
MSFT
|
$280M |
Top Sells
| 1 |
NYX
NYSE EURONEXT INC
NYX
|
$186M |
| 2 |
Baxter International
BAX
|
$154M |
| 3 |
Amgen
AMGN
|
$140M |
| 4 |
Magna International
MGA
|
$80M |
| 5 |
RDS.B
Royal Dutch Shell PLC ADS Class B
RDS.B
|
$66.9M |
Sector Composition
| 1 | Healthcare | 16.16% |
| 2 | Industrials | 11.96% |
| 3 | Financials | 10.82% |
| 4 | Consumer Discretionary | 10.38% |
| 5 | Technology | 10.09% |
